Minnebio is happy to announce that our CEO, Dr. David Liang, participated in the 2024 BIO International Convention, held in San Diego, as part of the Minnesota Delegation alongside the Minnesota Department of Economic Development. This event is the largest and most comprehensive gathering of biotechnology professionals worldwide, bringing together over 18,500 industry leaders from across the biotech ecosystem, including pharmaceutical companies, startups, academic institutions, non-profits, government agencies, and investment firms.
As a leading innovator in biotechnology, Minnebio is committed to driving advancements in research and drug development. Dr. Liang’s attendance at BIO underscores our dedication to fostering collaboration and building strategic partnerships to advance progress in cancer immunotherapy, stem cell therapy, and custom-designed cell culture media for various scientific and therapeutic applications.
We look forward to leveraging the valuable insights and connections gained at the convention to enhance Minnebio’s global impact and contribute to shaping the future of biotechnology. We remain committed to forging meaningful connections and exploring opportunities for collaboration to achieve our shared goals.
SHARE
